3D structures from the PDB for "Dimer of Gag-Pol polyprotein [501-599,Q508K,L534I,L564I,C568A,C596A]" AND "BDBM8125"
(Proteins have >= 85% sequence identity and ligands are exact matches)


Seq IdentityJmol DisplayPDB Title
2IEN100%JmolCRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE WITH A POTENT NON-PEPTIDE INHIBITOR (UIC-94017)
3TKW100%JmolCRYSTAL STRUCTURE OF HIV PROTEASE MODEL PRECURSOR/DARUNAVIR COMPLEX
3CYW99%JmolEFFECT OF FLAP MUTATIONS ON STRUCTURE OF HIV-1 PROTEASE AND INHIBITION BY SAQUINAVIR AND DARUNAVIR
2F8099%JmolHIV-1 PROTEASE MUTANT D30N COMPLEXED WITH INHIBITOR TMC114
3PWM99%JmolHIV-1 PROTEASE MUTANT L76V WITH DARUNAVIR
2IEO99%JmolCRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT I84V WITH A POTENT NON-PEPTIDE INHIBITOR (UIC-94017)
3D2099%JmolCRYSTAL STRUCTURE OF HIV-1 MUTANT I54V AND INHIBITOR DARUNAVIA
2IDW99%JmolCRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT V82A WITH A POTENT NON-PEPTIDE INHIBITOR (UIC-94017)
2HS199%JmolULTRA-HIGH RESOLUTION X-RAY CRYSTAL STRUCTURE OF HIV-1 PROTEASE V32I MUTANT WITH TMC114 (DARUNAVIR) INHIBITOR
2HS299%JmolCRYSTAL STRUCTURE OF M46L MUTANT OF HIV-1 PROTEASE COMPLEXED WITH TMC114 (DARUNAVIR)
2F8G99%JmolHIV-1 PROTEASE MUTANT I50V COMPLEXED WITH INHIBITOR TMC114
2F8199%JmolHIV-1 PROTEASE MUTANT L90M COMPLEXED WITH INHIBITOR TMC114
3BVB99%JmolCYSTAL STRUCTURE OF HIV-1 ACTIVE SITE MUTANT D25N AND INHIBITOR DARUNAVIR
3D1Z99%JmolCRYSTAL STRUCTURE OF HIV-1 MUTANT I54M AND INHIBITOR DARUNAVIR
3JW299%JmolHIV-1 PROTEASE MUTANT G86S WITH DARUNAVIR
5KQY98%JmolPROTEASE E35D-DRV
4DQB97%JmolCRYSTAL STRUCTURE OF WILD-TYPE HIV-1 PROTEASE IN COMPLEX WITH DRV
3S5397%JmolHIV-1 PROTEASE TRIPLE MUTANTS V32I, I47V, V82I WITH ANTIVIRAL DRUG DARUNAVIR IN SPACE GROUP P212121
3S5497%JmolHIV-1 PROTEASE TRIPLE MUTANTS V32I, I47V, V82I WITH ANTIVIRAL DRUG DARUNAVIR IN SPACE GROUP P21212
5E5J97%JmolJOINT X-RAY/NEUTRON STRUCTURE OF HIV-1 PROTEASE TRIPLE MUTANT (V32I, I47V,V82I) WITH DARUNAVIR AT PH 6.0
5E5K97%JmolJOINT X-RAY/NEUTRON STRUCTURE OF HIV-1 PROTEASE TRIPLE MUTANT (V32I, I47V,V82I) WITH DARUNAVIR AT PH 4.3
4DQH96%JmolCRYSTAL STRUCTURE OF (R14C/E65C) HIV-1 PROTEASE IN COMPLEX WITH DRV
4DQE95%JmolCRYSTAL STRUCTURE OF (G16C/L38C) HIV-1 PROTEASE IN COMPLEX WITH DRV
4DQF95%JmolCRYSTAL STRUCTURE OF (G16A/L38A) HIV-1 PROTEASE IN COMPLEX WITH DRV
4DQC95%JmolCRYSTAL STRUCTURE OF (G16C/L38C) HIV-1 PROTEASE IN COMPLEX WITH DRV
6OPS95%JmolHIV-1 PROTEASE NL4-3 WT IN COMPLEX WITH DARUNAVIR
6DGX95%JmolCRYSTAL STRUCTURE OF HIV-1 PROTEASE NL4-3 WT IN COMPLEX WITH DARUNAVIR
4HLA95%JmolCRYSTAL STRUCTURE OF WILD TYPE HIV-1 PROTEASE IN COMPLEX WITH DARUNAVIR
4LL394%JmolSTRUCTURE OF WILD-TYPE HIV PROTEASE IN COMPLEX WITH DARUNAVIR
6DH394%JmolCRYSTAL STRUCTURE OF HIV-1 PROTEASE NL4-3 V82I MUTANT IN COMPLEX WITH DARUNAVIR
6DH094%JmolCRYSTAL STRUCTURE OF HIV-1 PROTEASE NL4-3 I84V MUTANT IN COMPLEX WITH DARUNAVIR
6DH694%JmolCRYSTAL STRUCTURE OF HIV-1 PROTEASE NL4-3 I50V MUTANT IN COMPLEX WITH DARUNAVIR
5KR194%JmolPROTEASE PR5-DRV
6OOU94%JmolCRYSTAL STRUCTURE OF HIV-1 PROTEASE NL4-3 L89V MUTANT IN COMPLEX WITH DARUNAVIR
6OOS94%JmolHIV-1 PROTEASE NL4-3 L90M MUTANT IN COMPLEX WITH DARUNAVIR
6OPT93%JmolHIV-1 PROTEASE NL4-3 V82F, I84V MUTANT IN COMPLEX WITH DARUNAVIR
6OOT93%JmolHIV-1 PROTEASE NL4-3 L89V, L90M MUTANT IN COMPLEX WITH DARUNAVIR
3OY492%JmolCRYSTAL STRUCTURE OF HIV-1 L76V PROTEASE IN COMPLEX WITH THE PROTEASE INHIBITOR DARUNAVIR.
4Q1Y92%JmolMUTATIONS OUTSIDE THE ACTIVE SITE OF HIV-1 PROTEASE ALTER ENZYME STRUCTURE AND DYNAMIC ENSEMBLE OF THE ACTIVE SITE TO CONFER DRUG RESISTANCE
4Q1X92%JmolMUTATIONS OUTSIDE THE ACTIVE SITE OF HIV-1 PROTEASE ALTER ENZYME STRUCTURE AND DYNAMIC ENSEMBLE OF THE ACTIVE SITE TO CONFER DRUG RESISTANCE
4Q1W92%JmolMUTATIONS OUTSIDE THE ACTIVE SITE OF HIV-1 PROTEASE ALTER ENZYME STRUCTURE AND DYNAMIC ENSEMBLE OF THE ACTIVE SITE TO CONFER DRUG RESISTANCE
1T7I92%JmolTHE STRUCTURAL AND THERMODYNAMIC BASIS FOR THE BINDING OF TMC114, A NEXT-GENERATION HIV-1 PROTEASE INHIBITOR.
1T3R92%JmolHIV PROTEASE WILD-TYPE IN COMPLEX WITH TMC114 INHIBITOR
6OPU91%JmolHIV-1 PROTEASE NL4-3 K45I, M46I, V82F, I84V MUTANT IN COMPLEX WITH DARUNAVIR
3OXW90%JmolCRYSTAL STRUCTURE OF HIV-1 I50V, A71V PROTEASE IN COMPLEX WITH THE PROTEASE INHIBITOR DARUNAVIR
7MAS90%JmolDRUG RESISTANT HIV-1 PROTEASE (L10F, M46I, I50V, F53L, L63P, G73S) IN COMPLEX WITH DRV
7MAQ89%JmolDRUG RESISTANT HIV-1 PROTEASE (L10F, V32I, L33F, K45I, A71V, V82I, I84V) IN COMPLEX WITH DRV
3LZS89%JmolCRYSTAL STRUCTURE OF HIV-1 CRF01_AE PROTEASE IN COMPLEX WITH DARUNAVIR
3EKT89%JmolCRYSTAL STRUCTURE OF THE INHIBITOR DARUNAVIR (DRV) IN COMPLEX WITH A MULTI-DRUG RESISTANT HIV-1 PROTEASE VARIANT (L10F/G48V/I54V/V64I/V82A) (REFER: FLAP+ IN CITATION.)
6OPV88%JmolHIV-1 PROTEASE NL4-3 I13V, G16E, V32I, L33F, K45I, M46I, V82F, I84V MUTANT IN COMPLEX WITH DARUNAVIR
3LZU88%JmolCRYSTAL STRUCTURE OF A NELFINAVIR RESISTANT HIV-1 CRF01_AE PROTEASE VARIANT (N88S) IN COMPLEX WITH THE PROTEASE INHIBITOR DARUNAVIR.
7MAP87%JmolDRUG RESISTANT HIV-1 PROTEASE (L10I, V32I, L33F, K45I, M46I, I50V, A71V, V82I, I84V) IN COMPLEX WITH DRV
6OPW87%JmolHIV-1 PROTEASE NL4-3 I13V, G16E, V32I, L33F, K45I, M46I, A71V, V82F, I84V MUTANT IN COMPLEX WITH DARUNAVIR
6OPX87%JmolHIV-1 PROTEASE NL4-3 I13V, G16E, V32I, L33F, K45I, M46I, L76V, V82F, I84V MUTANT IN COMPLEX WITH DARUNAVIR
6OPY86%JmolHIV-1 PROTEASE NL4-3 I13V, G16E, V32I, L33F, K45I, M46I, A71V, L76V, V82F, I84V MUTANT IN COMPLEX WITH DARUNAVIR
4NPT86%JmolCRYSTAL STRUCTURE OF HIV-1 PROTEASE MULTIPLE MUTANT P51 COMPLEXED WITH DARUNAVIR